CD81 inhibits the proliferation of astrocytes by inducing G₀/G₁ arrest in vitro

Abstract

Astrocytes play a major role in the reactive processes in response to neuronal injuries in the brain. Excessive gliosis is detrimental and can contribute to neuronal damage. CD81 (TAPA), a member of the tetraspanin family of proteins, is upregulated by astrocytes after traumatic injury to the rat central nervous system (CNS). To further understand the role of CD81 in the inhibition of astrocytes, we analyzed the effects of a CD81 antibody, on cultured rat astrocytes. The results indicated that the effect worked in a dose-dependent manner with certain dosage range. It, however, reached a dosage equilibrium at a high dosage. Furthermore, anti-CD81 antibody remarkably inhibited the proliferation of astrocytes after incubation with astrocytes for different periods of time and the effect presented a time-dependent fashion. However, anti-CD81 antibody substantially inhibited the proliferation of astrocytes at low density and middle density but slightly inhibited the proliferation of astrocytes at high density, suggesting that the effect was positively correlated with the proliferative ability of astrocytes. Finally, the cell cycle of astrocytes exposured to anti-CD81 antibody was arrested in S phase at the initial stage and at G₀/G₁ phase over time. These findings indicated that CD81 exert significant inhibitory effect, dose-dependently and time-dependently, on the proliferation of astrocytes and the effect is positively correlated with the proliferative capability of astrocytes.

Keywords

CD81 / astrocytes / proliferation / inhibition / cell cycle / tetraspanins

References

[1] ByrnesK.R., FadenA.I.. Role of cell cycle proteins in CNS injury. Neurochem Res, 2007, 32(10): 1799-1807

[2] BoucheixC., RubinsteinE.. Tetraspanins. Cell Mol Life Sci, 2001, 58(9): 1189-1205

[3] BalfeP., McKeatingJ.A.. The complexities of hepatitis C virus entry. J Hepatol, 2009, 51(3): 609-611

[4] CharrinS., le NaourF., SilvieO., et al.. Lateral organization of membrane proteins: tetraspanins spin their web. Biochem J, 2009, 420(2): 133-154

[5] DelandreC., PenabazT.R., PassarelliA.L., et al.. Mutation of juxtamembrane cysteines in the tetraspanin CD81 affects palmitoylation and alters interaction with other proteins at the cell surface. Exp Cell Res, 2009, 315(11): 1953-1963

[6] DreuxM., Dao ThiV.L., FresquetJ., et al.. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog, 2009, 5(2): e1000310

[7] GrigorovB., Attuil-AudenisV., PerugiF., et al.. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology, 2009, 6: 28

[8] KrementsovD.N., WengJ., LambeleM., et al.. Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology, 2009, 6: 64

[9] MordicaW.J., WoodsK.M., ClemR.J., et al.. Macrophage cell lines use CD81 in cell growth regulation. In Vitro Cell Dev Biol Anim, 2009, 45(5–6): 213-225

[10] StaflinK., ZuchnerT., HonethG., et al.. Identification of proteins involved in neural progenitor cell targeting of gliomas. BMC Cancer., 2009, 9: 206

[11] RohlenaJ., VolgerO.L., van BuulJ.D., et al.. Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion. Cardiovasc Res, 2009, 81(1): 187-196

[12] GeisertE.E.Jr., AbelH.J., FanL., et al.. Retinal pigment epithelium of the rat express CD81, the target of the anti-proliferative antibody (TAPA). Invest Ophthalmol Vis Sci, 2002, 43(1): 274-280

[13] SullivanC.D., GeisertE.E.Jr. Expression of rat target of the antiproliferative antibody (TAPA) in the developing brain. J Comp Neurol, 1998, 396(3): 366-380

[14] GeisertE.E.Jr, YangL., IrwinM.H., et al.. Astrocyte growth, reactivity, and the target of the antiproliferative antibody, TAPA. J Neurosci, 1996, 16(17): 5478-5487

[15] GeisertE.E.Jr., WilliamsR.W., GeisertG.R., et al.. Increased brain size and glial cell number in CD81-null mice. J Comp Neurol, 2002, 453(1): 22-32

[16] PanY., BrownC., WangX., et al.. The developmental regulation of CD81 in the rat retina. Mol Vis, 2007, 13: 181-189

[17] GensertJ.M., BaranovaO.V., WeinsteinD.E., et al.. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells. Neurobiol Dis., 2007, 26(3): 671-680

[18] SchwartzJ.P., WilsonD.J.. Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia, 1992, 5(1): 75-80

[19] YamamotoT., YuyamaK., NakamuraK., et al.. Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release. Eur J Pharmacol, 2000, 397(1): 25-33

[20] MaeckerH.T.. Human CD81 directly enhances Th1 and Th2 cell activation, but preferentially induces proliferation of Th2 cells upon long-term stimulation. BMC Immunol, 2003, 19(4): 1

[21] KelicS., LevyS., SuarezC., et al.. CD81 regulates neuron-induced astrocyte cell-cycle exit. Mol Cell Neurosci, 2001, 17(3): 551-560

[22] DijkstraS., GeisertE.E.Jr., DijkstraC.D., et al.. CD81 and microglial activation in vitro: proliferation, phagocytosis and nitric oxide production. J Neuroimmunol, 2001, 114(1–2): 151-159

[23] OrenR., TakahashiS., DossC., et al.. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol, 1990, 10(8): 4007-4015

[24] CernakI., StoicaB., ByrnesK.R., et al.. Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle, 2005, 4(9): 1286-1293

[25] KatoH., TakahashiA., ItoyamaY.. Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat. Brain Res Bull, 2003, 60(3): 215-221